In brief: Medline’s IPO, GLP-1's expansion, DME’s ‘hidden cost,’ Nymbl’s investment
NORTHFIELD, Ill. – Medline has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares to be offered and the price …